| Product Code: ETC9819946 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Turkey Neurodegenerative Disease Treatment Market Overview |
3.1 Turkey Country Macro Economic Indicators |
3.2 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Turkey Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 Turkey Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 Turkey Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in Turkey |
4.2.2 Advancements in medical research leading to the development of innovative treatments |
4.2.3 Growing aging population in Turkey requiring more neurodegenerative disease treatments |
4.3 Market Restraints |
4.3.1 High treatment costs associated with neurodegenerative disease treatments |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Turkey |
4.3.3 Regulatory hurdles and slow approval processes for new treatments |
5 Turkey Neurodegenerative Disease Treatment Market Trends |
6 Turkey Neurodegenerative Disease Treatment Market, By Types |
6.1 Turkey Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Turkey Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Turkey Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Turkey Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Turkey Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Turkey Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 Turkey Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 Turkey Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 Turkey Neurodegenerative Disease Treatment Market Key Performance Indicators |
8.1 Number of clinical trials for neurodegenerative disease treatments in Turkey |
8.2 Patient satisfaction rates with available treatments |
8.3 Adoption rate of new treatment modalities in Turkey |
8.4 Number of healthcare professionals specializing in neurodegenerative diseases in Turkey |
8.5 Government funding allocated to neurodegenerative disease research and treatment in Turkey |
9 Turkey Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 Turkey Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Turkey Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 Turkey Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 Turkey Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 Turkey Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 Turkey Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Turkey Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here